R-Cure Medical and Kent Imaging announce distribution agreement for SnapshotNIR

R-Cure Medical, Israel, and Kent Imaging are pleased to announce that they have signed a distribution agreement for Kent's innovative medical imaging device in Israel. Kent’s SnapshotNIR technology instantly diagnoses oxygenation of tissue. The technology enables clinicians to make better decisions in a variety of cases, such as:
 
Wound Care Treatment Path - helps clinicians distinguish between sufficiently oxygenated wounds that will heal over time and those that are not adequately oxygenated and will require more advanced treatments to recover.

Plastic Surgery - determining a skin flap has limited blood supply earlier may lead to less patient suffering and significantly reduced healthcare costs.

Oxygen is the key to healing. The ability to detect blood supply to the tissue and understand tissue oxygen saturation is a crucial indicator of tissue health.

R-Cure Medical is proud to provide wound care plastic surgeons, wound care physicians, and nurses, with a tool that will enable them to receive a comprehensive picture of tissue health and support their clinical decisions.

R-Cure Medical provides medical innovations for the treatment and prevention of hard to heal wounds, pressure sores, and infections. R-Cure Medical markets products that are approved by the Ministry of Health and comply with international standards. Their customers include hospitals, health funds, the Ministry of Health, the Ministry of Defense, rehabilitation institutions, clinics, pharmacies as well as private individuals.

To read more about how SnapshotNIR is changing the game in advanced tissue oxygenation imaging, visit our product page.